The vulnerable endothelium-Reference-Cited by-同舟云学术

The vulnerable endothelium

Published:2005-08 Issue:2 Volume:150 Page:189-192
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Becker Richard C.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Enoxaparin vs unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial;Ferguson;JAMA,2004

2. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non–ST-segment elevation acute coronary syndromes: a systematic overview;Petersen;JAMA,2004

3. Anti-inflammatory mechanisms in the vascular wall;Tedgui;Circ Res,2001

4. Nitric oxide: an endogenous modulator of leukocyte adhesion;Kubes;Proc Natl Acad Sci U S A,1991

5. Induction of monocyte binding to endothelial cells by MM-LDL: role of lipoxygenase metabolites;Honda;Arterioscler Thromb Vasc Biol,1999

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Concentration of Biomarkers Reflecting Endothelial Cell- and Glycocalyx Damage are Increased in Patients With Suspected ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock;Shock;2018-11

2. Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis;PLOS ONE;2017-05-23

3. Sympathoadrenal Activation and Endothelial Damage Are Inter Correlated and Predict Increased Mortality in Patients Resuscitated after Out-Of-Hospital Cardiac Arrest. A Post Hoc Sub-Study of Patients from the TTM-Trial;PLOS ONE;2015-03-19

4. Looking at the proteases from a simple perspective;Journal of Molecular Recognition;2011-02-25

5. The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial (Am J Heart 2005;150:189-92);American Heart Journal;2006-05